event-trade登录编辑
RTTNews BiotechCodex · 实盘不做把握 5/10
北京时间·🕒 发布 14:37:03时区推断·⟳ 抓取 14:45:28·⚡ 决策 07-13 21:32:28 +6h47m·106.0 天前

GSK公布Jemperli在dMMR/MSI-H局部晚期直肠癌AZUR-1注册性II期中期阳性结果

事件方向利好Jemperli商业前景,但GSK(GSK.US)约1040亿美元市值,单一适应症II期中期结果相对市值弹性不足。

📄 原文RTTNews Biotech↗ 原文
GSK Announces Positive Interim Results From Registrational Phase II AZUR-1 Trial Of Jemperli Business Latest Headlines…
不做 GSK(GSK.US)
Jemperli直肠癌数据方向正面但对GSK超千亿美元市值缺乏短线市值级增量,且当日股价未确认正反馈。
不做 AnaptysBio(ANAB.US)
ANAB虽有Jemperli royalty弹性,但该适应症积极数据早有铺垫、近20日已明显上涨且存在royalty诉讼,不适合追本次新闻。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-07-13 · 扩散 medium · price-in 风险 medium ↗ ↗ ↗

消息传播链

  1. 2026-07-13官方确认/否认GSK一手源原文 ↗
    GSK官方宣布AZUR-1注册性II期中期结果达到主要目标,并计划与全球监管机构沟通以支持审评。
    市场反应:GSK.US截至2026-07-13 13:30 UTC下跌1.63%,ANAB.US下跌2.58%。
  2. 2026-07-13 02:37 ET财经媒体扩散RTTNews非一手原文 ↗
    RTTNews在美东凌晨转述GSK公告,属于低延迟新闻扩散而非独家新信息。
  3. 2024-06-05其它GSK一手源原文 ↗
    同一药物在dMMR/MSI-H局部晚期直肠癌中此前已披露过高度积极结果,削弱本次数据的新鲜惊喜度。

关键理由

  • 事件方向利好Jemperli商业前景,但GSK(GSK.US)约1040亿美元市值,单一适应症II期中期结果相对市值弹性不足。
  • AnaptysBio(ANAB.US)对Jemperli享有8%-25%分级销售提成,理论弹性更高,但2024年同适应症已披露过高缓解率,本次更多是注册性验证而非全新发现。
  • 量级上,Jemperli 2026年Q1销售约2.32亿英镑、GSK指引峰值单药销售超过20亿英镑;直肠癌dMMR/MSI-H新增人群若获批可贡献增量销售,但落地仍需监管审评,ANAB按分级royalty获得的增量相对约19亿美元市值是中期可选项而非当日强交易催化。

主要风险

  • AnaptysBio(ANAB.US)近20日已涨约19%,且Jemperli royalty与拆分叙事已被市场持续交易,本次新闻当日开盘反而下跌。
  • GSK与AnaptysBio之间存在Jemperli许可/royalty诉讼,可能影响ANAB对未来现金流的估值折现。

反向证据

  • 做多前查反向 · 来源 web · 日期 2025-12 · 影响 weakens
    存在Jemperli许可/royalty诉讼,削弱ANAB对Jemperli增长的估值确定性。
    检索:GSK AnaptysBio Jemperli royalty litigation 2026 原文 ↗
  • 做多前查反向 · 来源 web · 日期 2024-06-05 · 影响 weakens
    同适应症此前已有高度积极数据,本次注册性中期数据的新鲜预期差有限。
    检索:GSK Jemperli rectal cancer 100% clinical complete response 2024 原文 ↗
  • 做多前查反向 · 来源 kb_search · 日期 2026-07-13 · 影响 none
    内部库命中当日GSK相关研报线索,但未显示足以把本次事件升级为强交易催化的新增量级证据。
    检索:GSK Jemperli dostarlimab rectal cancer AZUR-1 sales royalty AnaptysBio 原文 ↗
工具调用 · 历史记录,结果未知(2 种)
  • stock_quote · 结果未知
  • kb_search · 结果未知

原文全文

展开原文 · 7,357 字
GSK Announces Positive Interim Results From Registrational Phase II AZUR-1 Trial Of Jemperli
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Clinical Trial Results
By
RTTNews Staff Writer
✉
|
Published:
7/13/2026 2:37 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
GSK plc (
GSK
,
GSK.L
) reported positive interim results from the registrational phase II AZUR-1 trial of Jemperli in patients with stage II/III mismatch repair deficient/microsatellite instability-high locally advanced rectal cancer. The single arm trial met its primary objective, showing a meaningful and sustained clinical complete response rate at 12 months.
Dostarlimab has received both Breakthrough Therapy and Fast Track designations from the US FDA in this setting. GSK plans to share interim AZUR-1 data with global regulatory authorities to support review.
At last close, GSK plc shares were trading at 1,961.50 pence, up 0.10%.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Biotech Stocks Facing FDA Decision In May 2026
Latest Updates on Middle East War
U.S. Stocks May See Initial Weakness As Crude Oil Prices Surge
July 13, 2026 08:53 ET
Ships Stop Crossing Strait Of Hormuz As US-Iran Strikes Escalate
July 13, 2026 06:21 ET
U.S. Dollar Ticks Higher As U.S., Iran Set To Return To Negotiations After Recent Standoff
July 10, 2026 17:00 ET
Crude Oil Moves Lower As Middle East Tensions Gradually Ease
July 10, 2026 14:38 ET
Gold Slides Amid Increasing Inflation Concerns As U.S.-Iran Standoff Continues
July 10, 2026 13:46 ET
View More
Global Economics Weekly Update - June 29 - July 03, 2026
July 03, 2026 16:09 ET
A busy week for economic data saw the release of several reports on the labor market and the manufacturing sector. In the U.S., the jobs report for June was in focus and results of the latest ISM purchasing managers’ survey threw light on the health of the factory sector. In Europe, results of the PMI surveys gained attention while the unemployment figures from Germany were also in news. Similarly in Asia, survey data on the Chinese manufacturing sector was the highlight.
View More Videos
RELATED NEWS
GSK: Hansoh Pharma's Ris-Rez Shows Survival Benefit In Lung Cancer Trial
GSK Commences Tender Offer To Acquire Nuvalent For $124 Per Share
GSK Receives FDA And EMA Orphan Drug Designations For Momelotinib In VEXAS Syndrome
GSK: Momelotinib Granted Orphan Drug Designations In The US, EU
Latest Updates on COVID-19
KFF Poll Finds AI Health Chatbot Users More Likely To Believe Vaccine Myths
July 01, 2026 14:27 ET
New Study Shows Updated COVID Vaccine Reduces Severe Illness And Hospitalizations
June 24, 2026 13:12 ET
Editor's Pick
Most Read
Most Emailed
UK Imposes Sanctions On Russian Cyber Networks
July 13, 2026 08:25 ET
Jurassic Park Fame Film Star Sam Neill Dies
July 13, 2026 07:43 ET
Castlelake To Consider Options For EasyJet In View Of Apollo's Counter-Bid
July 10, 2026 11:27 ET
Delta Air Lines Q2 Profit Declines; Affirms FY26 Outlook
July 10, 2026 08:14 ET
U.S. Existing Home Sales Unexpectedly Pull Back Sharply In June
July 09, 2026 10:32 ET
U.S. Weekly Jobless Claims Unexpectedly Edge Down To 215,000
July 09, 2026 10:08 ET
PepsiCo Q2 Profit Surges, Core Margin Drops, Confirms FY26 View; Stock Down
July 09, 2026 09:38 ET
Cottonwood Fire Chars 558 Square Miles Of Utah
July 09, 2026 08:00 ET
Fed Minutes Confirm Mixed Views About Outlook For Rates
July 08, 2026 14:22 ET
Apple Signs Over $30 Bln Worth Chip Deal With Broadcom To Boost U.S. Manufacturing
July 08, 2026 09:13 ET
CDC Warns Of E. Coli Outbreak Linked To Frozen Blueberries
July 08, 2026 07:37 ET
Ebola Continues To Spread In DRC As Death Toll Passes 500, WHO Warns
July 08, 2026 07:30 ET
Accenture, Leonardo To Build NATO Secure Cloud Platform
July 08, 2026 01:18 ET
Judge Allows Lawsuit Over United's 'Window Seats' Without Windows To Proceed
July 08, 2026 17:37 ET
Netflix Explores Live TV And Bundles To Boost Viewer Engagement: WSJ Reports
July 10, 2026 01:12 ET
OpenAI Says GPT-5.6 Will Be Preferred AI Model For Microsoft 365 Copilot
July 10, 2026 16:33 ET
SFS To Acquire Heartland Precision Fasteners; Price Agreed To Be Confidential
July 10, 2026 03:42 ET
Dream Finders Homes Submits Revised Acquisition Proposal Of $32/Share To Beazer Homes USA
July 08, 2026 07:39 ET
Data I/O To Buy Embedded Software Security IP & Related Assets From IAR Systems For Undisclosed Sum
July 10, 2026 10:17 ET
AstraZeneca: CARDIO-TTRansform Phase III Trial For Wainua Fails To Meet Primary Efficacy Endpoint
July 09, 2026 02:30 ET
Columbus Circle Capital Announces Pricing Of 20 Mln Units IPO At $10/Unit
July 09, 2026 02:06 ET
Freedom Metals Acquisition Prices $275 Mln IPO At $10/unit
July 08, 2026 01:23 ET
Life Corp Profit Falls In Q1
July 08, 2026 01:24 ET
Genworth Financial CEO Tom McInerney To Take Temporary Leave Of Absence
July 08, 2026 01:30 ET
Kering's Gucci Brand To Break Deal With Coty Ahead Of Schedule; In 50-Year Licence Deal With L'Oréal
July 08, 2026 01:29 ET
MasTec To Acquire Superior Group
July 08, 2026 01:36 ET
FuelCell Energy Prices Upsized $225 Mln Stock Offering At $21/shr
July 08, 2026 01:33 ET
Rivian Automotive Prices Underwritten Public Offering Of 75 Mln Shares At $15.50/shr
July 08, 2026 02:02 ET
Admicom Oyj Profit Declines In Q2
July 08, 2026 01:55 ET
Senior Plc Raises Full-year Outlook On Strong Aerospace And Flexonics Performance
July 08, 2026 02:33 ET
NATO Chooses Saab GlobalEye As Future AEW&C Platform
July 08, 2026 01:59 ET
Vistry Group Chief Financial Officer Tim Lawlor To Step Down
July 08, 2026 02:41 ET
Editors Pick
General Mills Shares Gain On Higher Q4 Adj. Earnings, Sales Growth; $3 Bln Cost Savings Target
July 01, 2026 09:55 ET
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。